🔗 Share this article Individuals Stopping Slimming Injections Regain Pounds Four Times Faster Than Those on Conventional Diets Weight management involves ongoing approaches. New research reveals that people who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional diet and exercise regimens. Research printed in a major health publication demonstrates that while overweight individuals can lose a large proportion of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping. "Individuals using these drugs should be aware of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb. This pace of regain implies a return to pre-treatment mass within about one and a half years. Comparing Approaches The research, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting. Scientists point out that individuals who lose weight through dieting generally have a less rapid creep back—around 0.1 kg a month—after stopping. Understanding the Rapid Regain Nutrition scientists propose the mode of action of the jabs accounts for the amplified rebound. GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher. "Discontinuation of this hormone supplement leads to appetite is uncontrolled, making binge eating far more likely." An Ongoing Disease? Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications. A number of clinicians contend that, due to the high risk of weight regain, the therapy is often long-term. This view is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like hypertension. User Experiences Individuals who have discontinued the jabs explain a powerful resurgence of hunger. "It was like a switch flipping and you become ravenous," recalled a patient. The struggle is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during therapy. Growing Adoption Recent estimates indicate that millions of people in the UK have used these injections in the last 12 months, with demand continuing to grow. Adoption is higher among females than men. The 40s and 50s age group shows the highest usage rates. A large proportion access the drugs through private healthcare rather than the NHS. Ultimately, experts emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and maintained weight loss likely depends on integrated behavioural changes.
Weight management involves ongoing approaches. New research reveals that people who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional diet and exercise regimens. Research printed in a major health publication demonstrates that while overweight individuals can lose a large proportion of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month after stopping. "Individuals using these drugs should be aware of the risk of fast weight regain when the treatment concludes," warns expert Dr. Susan Jebb. This pace of regain implies a return to pre-treatment mass within about one and a half years. Comparing Approaches The research, which looked at dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting. Scientists point out that individuals who lose weight through dieting generally have a less rapid creep back—around 0.1 kg a month—after stopping. Understanding the Rapid Regain Nutrition scientists propose the mode of action of the jabs accounts for the amplified rebound. GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger. "Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher. "Discontinuation of this hormone supplement leads to appetite is uncontrolled, making binge eating far more likely." An Ongoing Disease? Health authorities suggest the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications. A number of clinicians contend that, due to the high risk of weight regain, the therapy is often long-term. This view is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term nature of obesity," comparing it to managing conditions like hypertension. User Experiences Individuals who have discontinued the jabs explain a powerful resurgence of hunger. "It was like a switch flipping and you become ravenous," recalled a patient. The struggle is exacerbated if individuals have not adopted permanent lifestyle or habit modifications during therapy. Growing Adoption Recent estimates indicate that millions of people in the UK have used these injections in the last 12 months, with demand continuing to grow. Adoption is higher among females than men. The 40s and 50s age group shows the highest usage rates. A large proportion access the drugs through private healthcare rather than the NHS. Ultimately, experts emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and maintained weight loss likely depends on integrated behavioural changes.